2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine has been researched along with Asthma, Bronchial in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Broide, DH; Datta, SK; Fermin, A; Häcker, H; Pitha, PM; Raz, E; Redecke, V | 1 |
1 other study(ies) available for 2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine and Asthma, Bronchial
Article | Year |
---|---|
Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma.
Topics: Adjuvants, Immunologic; Animals; Asthma; B7-1 Antigen; Cells, Cultured; Cysteine; Cytokines; Immunity, Innate; Immunophenotyping; Inducible T-Cell Co-Stimulator Ligand; Ligands; Lipoproteins; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Oligodeoxyribonucleotides; Ovalbumin; Receptors, Cell Surface; Th2 Cells; Toll-Like Receptor 2; Toll-Like Receptors | 2004 |